Clincosm LogoSign in Get a demo

triple negative breast neoplasms

Showing 26 - 39 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Tumors Trial in Saint Louis (Docetaxel, Carboplatin, FDG-PET/MR)

Terminated
  • Triple Negative Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 6, 2022

Breast Cancer, Triple Negative Breast Tumors Trial in Sweden (epirubicin, cyclophosphamide, paclitaxel, carboplatin, epirubicin,

Recruiting
  • Breast Cancer
  • Triple Negative Breast Neoplasms
  • epirubicin, cyclophosphamide, paclitaxel, carboplatin
  • epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin
  • Borås, Sweden
  • +15 more
Jan 3, 2022

Triple Negative Breast Tumors, Breast Cancer Trial in Chicago (Pembrolizumab, Mifepristone)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Breast Cancer
  • Chicago, Illinois
    University of Chicago
Nov 12, 2021

Triple Negative Breast Tumors Trial in Poland (Palbociclib, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Wrocław, Dolnośląskie, Poland
  • +5 more
Oct 4, 2021

Tumors, Tumor Metastasis, Triple Negative Breast Tumors Trial in Edmonton, Montreal (LY3295668)

Completed
Has Results
  • Neoplasms
  • +6 more
  • Edmonton, Alberta, Canada
  • +2 more
Jun 29, 2021

Triple Negative Breast Tumors Trial

Not yet recruiting
  • Triple Negative Breast Neoplasms
    • (no location specified)
    Dec 9, 2020

    Triple Negative Breast Tumors Trial (Pembrolizumab, Nab-paclitaxel, Anthracycline (doxorubicin))

    Completed
    Has Results
    • Triple Negative Breast Neoplasms
    • Pembrolizumab
    • +5 more
    • (no location specified)
    Aug 21, 2020

    Triple Negative Breast Cancer, Triple-Negative Breast Cancer, Triple Negative Breast Tumors Trial in Saint Louis (Personalized

    Completed
    • Triple Negative Breast Cancer
    • +2 more
    • Personalized polyepitope DNA vaccine
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 30, 2020

    Breast Cancer, Triple Negative Breast Tumors, HRpos Breast Tumors Trial in Germany (drug, procedure, other)

    Completed
    • Breast Cancer
    • +3 more
    • Esslingen am Neckar, Baden-Württemberg, Germany
    • +11 more
    Mar 13, 2020

    Triple Negative Breast Tumors Trial in Worldwide (PF-03084014)

    Terminated
    Has Results
    • Triple Negative Breast Neoplasms
    • Stanford, California
    • +36 more
    Dec 19, 2018

    Triple Negative Breast Tumors Trial in Harbin (SCT200)

    Unknown status
    • Triple Negative Breast Neoplasms
    • SCT200
    • Harbin, Heilongjiang, China
      Cancer Hospital Affiliated to Harbin Medical University
    Sep 29, 2018

    Triple-negative Breast Cancer: a New Perspective on Biomarkers

    Completed
    • Triple Negative Breast Neoplasms
    • Triple Negative Breast Cancer
      • Rio De Janeiro, Brazil
        Instituto Nacional do Cancer - CPQ
      May 29, 2018

      Breast Cancer, Triple Negative Breast Tumors, Triple-Negative Breast Tumor Trial (Bavituximab, Taxane)

      Withdrawn
      • Breast Cancer
      • +6 more
      • (no location specified)
      Mar 8, 2017

      Triple Negative Breast Tumors Trial in Xi'an (Chemo, Immunotherapy)

      Withdrawn
      • Triple Negative Breast Neoplasms
      • Xi'an, Shaanxi, China
        the First Affiliated Hospital of Xi 'an Jiaotong University
      Aug 9, 2016